Evaluate meaningful outcomes at twelve weeks
Alfthan G, Aro A, and Gey KF (1997)
Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Regimens Containing High-Dose Cytarabine
This is why we strongly recommend: Using a cycling protocol (periods of use followed by planned breaks) rather than continuous, indefinite use
To book an appointment at our Alabama or Georgia IV therapy locations, please get in touch with our team at any convenient time
GHK-CU Key Health Benefits: Stimulates collagen production Skin Regeneration and Wound Healing Anti-Aging Anti-Inflammatory and Antioxidant Promotes Hair Growth Protects against oxidative stress Supports Brain Health Improves nervous system health Chronic Disease Management Need supplies